Last synced on 21 February 2025 at 11:05 pm

Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

Page Type
Product Code
Definition
to treat lung failure due to COVID-19 when used as an adjunct to noninvasive or invasive mechanical ventilation in reducing hypercapnia and hypercapnic acidosis due to Coronavirus Disease 2019 (COVID-19), and/or maintaining normalized levels of partial pressure of carbon dioxide (PCO2) and pH in patients suffering from acute, reversible respiratory failure due to COVID-19 for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved.
Physical State
The device looks like an ECMO system
Technical Method
uses partial pressures between the circulating blood and the sweep gas to allow sufficient gas exchange to treat hypercapnia
Target Area
The device is part of an extracorporeal circuit and exchanges the blood gases within the device, outside of the body while the blood is circulated in the extracorporeal circuit.
Review Panel
Cardiovascular
Submission Type
EUA - Emergency Use Authorization
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code QLN is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.

Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

Page Type
Product Code
Definition
to treat lung failure due to COVID-19 when used as an adjunct to noninvasive or invasive mechanical ventilation in reducing hypercapnia and hypercapnic acidosis due to Coronavirus Disease 2019 (COVID-19), and/or maintaining normalized levels of partial pressure of carbon dioxide (PCO2) and pH in patients suffering from acute, reversible respiratory failure due to COVID-19 for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved.
Physical State
The device looks like an ECMO system
Technical Method
uses partial pressures between the circulating blood and the sweep gas to allow sufficient gas exchange to treat hypercapnia
Target Area
The device is part of an extracorporeal circuit and exchanges the blood gases within the device, outside of the body while the blood is circulated in the extracorporeal circuit.
Review Panel
Cardiovascular
Submission Type
EUA - Emergency Use Authorization
Device Classification
N
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

As product code QLN is assigned to devices that are "not-classified", it is not linked to any specific regulation and CFR section.